Zydus’ Nesher Pharma gets USFDA nod to market influenza drug Industry-The Economic Times — September 16, 2017 comments off Zydus’ Nesher Pharmaceuticals has received final approval from the USFDA to market Oseltamivir powder for oral suspension, 6 mg/ml, said the company.
Zydus’ Nesher Pharmaceuticals has received final approval from the USFDA to market Oseltamivir powder for oral suspension, 6 mg/ml, said the company.